| Actinomycetales| Actinomycetales Buchanan 1917 (Approved Lists 1980) emend Stackebrandt et al. 1997| Actinomycetales Buchanan 1917 (Approved Lists 1980) emend. Zhi et al. 2009| Actinomycineae| Actinomycineae Stackebrandt et al. 1997 emend. Zhi et al. 2009
Positive Impacts:
Antibiotic Production: Some Actinomycetales bacteria are known for their ability to produce antibiotics. Streptomyces, a genus within Actinomycetales, is particularly well-known for producing antibiotics like streptomycin, erythromycin, and tetracycline. These antibiotics have been crucial in treating various bacterial infections in humans.
Bioremediation: Some Actinomycetales species are involved in bioremediation processes, contributing to the breakdown of organic matter in the environment. This can have positive effects on ecosystem health and reduce the impact of pollutants.
Negative Impacts:
Pathogenic Species: While many Actinomycetales are harmless, some can be pathogenic and cause infections in humans. For example, Actinomyces is a genus within this order that includes species responsible for actinomycosis, a rare but potentially serious infection that can affect various body tissues.
Mycobacterium tuberculosis: Mycobacterium tuberculosis, the causative agent of tuberculosis, is a member of the order Actinomycetales. Tuberculosis is a respiratory disease that can have significant health impacts if left untreated.
Environmental Impact:
Fermentation and Food Production:
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 4.99 | 0 | 0 | 10 | 86380 | 0 | 17230 | 1276 | 180 | 8139.7 | 0 | 820 | 0 %ile | 100 %ile |
biomesight | 91.66 | 650 | 100 | 770 | 0 | 46900 | 1892 | 270 | 22963.4 | 10 | 810 | 8 %ile | 90.6 %ile | |
thorne | 100 | 105 | 11017 | 0 | 4831 | 849.9 | 337 | 2030.9 | 51 | 691 | 0 %ile | 100 %ile | ||
thryve | 88.27 | 0 | 323 | 37 | 396 | 0 | 7696 | 516.1 | 132 | 3663.4 | 0 | 483 | 11.6 %ile | 90.1 %ile |
ubiome | 84.54 | 0 | 1050 | 20 | 1877 | 0 | 27690 | 3241.7 | 442 | 12473.6 | 0 | 1892 | 0 %ile | 92 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 40.64 | 117.36 | 0.0041 | 0.0117 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 40 % | 0.053 % | 0.116 % | 6.0 | 15 |
BiomeSight | 97.94 % | 0.173 % | 2.045 % | 2805.0 | 2864 |
BiomeSightRdp | 78.125 % | 0.011 % | 0.014 % | 25.0 | 32 |
bugspeak | 100 % | 0.04 % | % | 1.0 | 1 |
CerbaLab | 66.667 % | 0.029 % | 0.017 % | 2.0 | 3 |
CosmosId | 90.625 % | 0.084 % | 0.167 % | 29.0 | 32 |
custom | 23.729 % | 0.005 % | 0.005 % | 14.0 | 59 |
es-xenogene | 48.276 % | 0.016 % | 0.024 % | 14.0 | 29 |
Medivere | 100 % | 0.078 % | 0.048 % | 7.0 | 7 |
Microba | 10.714 % | 0.077 % | 0.051 % | 3.0 | 28 |
SequentiaBiotech | 66.667 % | 0.07 % | 0.081 % | 24.0 | 36 |
Thorne | 85.227 % | 0.049 % | 0.136 % | 75.0 | 88 |
Thryve | 88.792 % | 0.051 % | 0.342 % | 1228.0 | 1383 |
Tiny | 100 % | 8.638 % | % | 1.0 | 1 |
uBiome | 84.217 % | 0.324 % | 1.247 % | 667.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.